May 24, 2018 / 11:15 AM / 5 months ago

BRIEF-AcelRx Announces FDA Acceptance Of NDA For Dsuvia

May 24 (Reuters) - AcelRx Pharmaceuticals Inc:

* ACELRX PHARMACEUTICALS INC - DSUVIA PDUFA DATE SET FOR NOVEMBER 3, 2018

* ACELRX ANNOUNCES FDA ACCEPTANCE OF NDA FOR DSUVIA

* ACELRX PHARMACEUTICALS INC - FDA CONSIDERS DSUVIA NDA RESUBMISSION A COMPLETE CLASS 2 RESPONSE TO THEIR OCTOBER 2017 ACTION LETTER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below